Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Parasite lipid membranes are complex, dynamic structures that define the boundary of the parasite, playing a vital role in maintaining osmotic balance, acquiring nutrients from the host, and mediating signal transduction (Source: Journal of Lipid Research). These membranes often contain unique lipid species or sterols, such as ergosterol in many protozoa, which are absent in human cells and thus serve as selective targets for chemotherapy (Source: Nature Reviews Microbiology). For example, the polyene antifungal Amphotericin B exploits the presence of ergosterol to induce pore formation and subsequent parasite lysis (Source: StatPearls). Other agents like miltefosine, an alkylphosphocholine, interfere with phospholipid metabolism and membrane-anchored signaling (Source: WHO). While effective, targeting the lipid membrane is often limited by the structural similarities between parasite and host lipids, which can lead to significant adverse effects such as hemolysis and renal impairment (Source: PubMed). Understanding the specific lipidomic profile of different parasites remains a key area for developing more selective and less toxic anti-parasitic interventions.
Drugs targeting the parasite lipid membrane typically function by binding to specific membrane components like ergosterol or phospholipids, leading to the formation of aqueous pores, alteration of membrane fluidity, or disruption of lipid-mediated signaling pathways, which results in the loss of intracellular contents and cell death (Source: StatPearls, PubMed).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Parasite lipid membrane.